F. Christopher Bi et al. / Tetrahedron Letters 49 (2008) 1832–1835
1835
the corresponding 3-(4-methylsulfonylphenylamino) compounds
15b–d. Removal of the PMB protecting group with TES/TFA in
dichloromethane yielded the equivalent products 9, 10, and 11.
based on a microwave-mediated Smiles rearrangement. A
selection of readily available 3-halopyrazin-2-amines and
PMB
H
N
R1
R2
N
N
OPMB
NH2
R1
R2
O
SO2Me
R1
R2
N
X
R1
R2
N
N
O
SO2Me
a
b
c
N
N
H
N
NH2
N
H
14b-d
9-11
5b-d
15b-d
o
(a) PMBOH, t-BuOK, dioxane, Δ; (b) NaH, 4-fluorophenyl methyl sulfone, DMF, 80 C; (c) Et3SiH, TFA, CH2Cl2.
7. Representative procedure: A 2–5 mL microwave vial equipped with a
stir-bar was charged with 2-amino-3-chloroquinoxaline (5b) (180 mg,
1.0 mmol), 4-methylsulfonylphenol (6a) (207 mg, 1.2 mmol) and
potassium carbonate (691 mg, 5.0 mmol). 1-Methyl-2-pyrrolidinone
(NMP, 3.5 mL) was added, and the vessel was subsequently sealed
and heated to 200 °C in the microwave reactor (Biotage Initiator) for
30 min. The reaction mixture was cooled to rt, diluted with 20 mL of
water, and acidified to pH 2 with 1 N HCl. The resulting precipitate
was collected via a medium-pore frit funnel, and washed sequentially
with water (20 mL) and MeOH (2 mL). The residue was dried in
vacuo to give 3-(4-(methylsulfonyl)phenylamino)quinoxalin-2(1H)-
one (9) as a yellow solid (270 mg, 86%). 1H NMR (400 MHz, DMSO-
d6) d 12.57 (s, 1H), 9.91 (s, 1H), 8.42 (d, 2H, J = 8.9), 7.86 (d, 2H,
J = 8.9), 7.56 (d, 1H, J = 7.5), 7.21–7.30 (m, 3H), 3.17 (s, 3H). 13C
NMR (100 MHz, DMSO-d6) d 152.03, 147.85, 144.86, 134.26, 132.36,
129.57, 128.54, 126.53, 126.41, 124.27, 120.10, 115.83, 44.57. IR (neat)
3293, 1680, 1599, 1574, 1554, 1539, 1287, 1135, 1088, 795, 772, 752,
716, 606, 579, 535 cmÀ1. HRMS: Calcd for C15H14N3O3S (MH+):
316.0750, found: 316.0747.
3-haloquinoxalin-amines, and phenols with a range of
electronic properties and substitution patterns can be
employed successfully in this rearrangement reaction. To
the best of our knowledge, this constitutes the first pub-
lished account of a Smiles rearrangement of amino-aryloxy
substituted pyrazines and quinoxalines.
Acknowledgments
We would like to thank Mr. Robert M. Oliver for the
preparation of substrates 5b and 5c. We thank Dr. Antonio
DiPasquale of UCSD for solving the X-ray structure of 9
and Dr. Jon Bordner of Pfizer for solving the X-ray struc-
ture of 13f.
References and notes
8. The data collection for 9 was carried out at the University of
California—San Diego X-ray facility using direct methods (SIR-97)
and refined with SHELXL-97: C15H13N3O3S; Fw = 315.34; yellow
needle, monoclinic; space group C2/c; unit cell dimensions: a =
1. Han, Y.; Giroux, A.; Colucci, J.; Bayly, C. I.; Mckay, D. J.; Roy, S.;
Xanthoudakis, S.; Vailancourt, J.; Rasper, D. M.; Tam, J.; Tawa, P.;
Nicholson, D. W.; Zamboni, R. J. Bioorg. Med. Chem. Lett. 2005, 15,
1173–1180.
2. Dudash, J., Jr.; Zhang, Y.; Moore, J. B.; Look, R.; Liang, Y.;
Beavers, M. P.; Conway, B. R.; Rybczynski, P. J.; Demarest, K. T.
Bioorg. Med. Chem. Lett. 2005, 15, 4790–4793.
3. Parlow, J. J.; Case, B. L.; Dice, T. A.; Fenton, R. L.; Hayes, M. J.;
Jones, D. E.; Neumann, W. L.; Wood, R. S.; Lachance, R. M.;
Girard, T. J.; Nicholson, N. S.; Clare, M.; Stegeman, R. A.; Stevens,
A. M.; Stallings, W. C.; Kurumbail, R. G.; South, M. S. J. Med.
Chem. 2003, 46, 4050–4062.
4. Heeres, J.; de Jonge, M. R.; Koymans, L. M. H.; Daeyaert, F. F. D.;
Vinkers, M.; Van Aken, K. J. A.; Arnold, E.; Das, K.; Kilonda, A.;
Hoornaert, G.; Compernolle, F.; Cegla, M.; Azzam, R. A.; Andries,
˚
˚
˚
22.8162(10) A, a = 90°; b = 5.4818(3) A, b = 101.342(2)°; c =
3
˚
22.7237(10) A, c = 90°; volume = 2786.6(2) A ; Z = 8; Dcalcd
=
1.503 Mg/m3; absorption coefficient = 2.227 mmÀ1; F(000) = 1312;
GOF on F2 = 1.132; final R indices [I > 2r(I)]: R1 = 0.0407, wR2 =
0.1154; R1 = 0.0463, wR2 = 0.1188 for all data.
9. (a) Jiang, B.; Yang, C.-G.; Xiong, W.-N.; Wang, J. Bioorg. Med.
Chem. Lett. 2001, 9, 1149–1154; (b) Camerino, B.; Palamidessi, G.
Gazz. Chim. Ital. 1960, 90, 1807.
10. Normal SNAr products were isolated as HCl salts with unexpected
low aqueous solubility. Salt formation was confirmed by 1H NMR of
the corresponding p-TsOH salt of 13f. Structural assignment of
normal SNAr products was confirmed by a single crystal X-ray
structure of compound 13f. The data for 13f were collected on a
Bruker APEX diffractometer at Pfizer Groton Laboratories, and all
crystallographic calculations were facilitated by the SHELXTL system:
´
K.; de Bethune, M.-P.; Azijn, H.; Pauwels, R.; Lewi, P. J.; Janssen, P.
A. J. J. Med. Chem. 2005, 48, 1910–1918.
5. For a review on Smiles rearrangement, see: (a) Truce, W. E.; Kreider,
E. M.; Brand, W. W. Org. React. 1970, 18, 99–215. For more recent
literature examples, see: (b) Xiang, J.; Zheng, L.; Chen, F.; Dang, Q.;
Bai, X. Org. Lett. 2007, 9, 765–767; (c) El Kaim, L.; Gizolme, M.;
Grimaud, L.; Oble, J. Org. Lett. 2006, 8, 4019–4021.
6. The C(5)–H signal became sharper when running the 1H NMR at
elevated temperature. Structure of similar Smiles rearrangement
products 9, 10, and 11 was confirmed through preparation via an
independent chemical route: Reaction of appropriate starting material
5b–d with p-methoxybenzylalcohol (PMB-OH) in the presence of
potassium tert-butoxide in hot dioxane gave the 2-PMB ethers 14b–d.
Deprotonation of these amines with sodium hydride followed by an
addition to 4-fluorophenyl methyl sulfone in DMF at 80 °C yielded
+
À
ꢀ
C14H11N3OF Cl ÁH2O; Fw = 309.72; triclinic; space group P1; unit
˚
˚
cell dimensions: a = 5.3954(2) A, a = 81.067(2)°; b = 8.8496(2) A,
˚
b = 88.690(2)°;
c = 15.1200(5) A,
c = 87.780(2)°;
volume =
712.54(4) A ; Z = 2; Dcalcd = 1.444 Mg/m3; absorption coefficient =
2.563 mmÀ1; F(000) = 320; GOF on F2 = 1.027; final R indices
[I > 2r(I)]: R1 = 0.0448, wR2 = 0.1289.
3
˚
11. Isolation of the normal SNAr product of the less reactive 4-
fluorophenol followed by subsequent re-subjection of it to prolonged
heating provided better yield than the one-pot procedure. Reaction of
the corresponding normal SNAr product of the more electron-rich 4-
methoxyphenol failed to give any desired rearrangement product,
even at higher temperature (T = 250 °C) and prolonged reaction time.